Literature DB >> 18296435

The runner's high: opioidergic mechanisms in the human brain.

Henning Boecker1, Till Sprenger, Mary E Spilker, Gjermund Henriksen, Marcus Koppenhoefer, Klaus J Wagner, Michael Valet, Achim Berthele, Thomas R Tolle.   

Abstract

The runner's high describes a euphoric state resulting from long-distance running. The cerebral neurochemical correlates of exercise-induced mood changes have been barely investigated so far. We aimed to unravel the opioidergic mechanisms of the runner's high in the human brain and to identify the relationship to perceived euphoria. We performed a positron emission tomography "ligand activation" study with the nonselective opioidergic ligand 6-O-(2-[(18)F]fluoroethyl)-6-O-desmethyldiprenorphine ([(18)F]FDPN). Ten athletes were scanned at 2 separate occasions in random order, at rest and after 2 h of endurance running (21.5 +/- 4.7 km). Binding kinetics of [(18)F]FDPN were quantified by basis pursuit denoising (DEPICT software). Statistical parametric mapping (SPM2) was used for voxelwise analyses to determine relative changes in ligand binding after running and correlations of opioid binding with euphoria ratings. Reductions in opioid receptor availability were identified preferentially in prefrontal and limbic/paralimbic brain structures. The level of euphoria was significantly increased after running and was inversely correlated with opioid binding in prefrontal/orbitofrontal cortices, the anterior cingulate cortex, bilateral insula, parainsular cortex, and temporoparietal regions. These findings support the "opioid theory" of the runner's high and suggest region-specific effects in frontolimbic brain areas that are involved in the processing of affective states and mood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18296435     DOI: 10.1093/cercor/bhn013

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  107 in total

Review 1.  Exercise-based treatments for substance use disorders: evidence, theory, and practicality.

Authors:  Sarah E Linke; Michael Ussher
Journal:  Am J Drug Alcohol Abuse       Date:  2014-11-14       Impact factor: 3.829

2.  Possible directions for the discovery of new antidepressant treatments.

Authors:  Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2011-01       Impact factor: 6.186

Review 3.  Effects of exercise and physical activity on depression.

Authors:  P C Dinas; Y Koutedakis; A D Flouris
Journal:  Ir J Med Sci       Date:  2010-11-14       Impact factor: 1.568

Review 4.  Can Doping be a Good Thing? Using Psychoactive Drugs to Facilitate Physical Activity Behaviour.

Authors:  Samuele Marcora
Journal:  Sports Med       Date:  2016-01       Impact factor: 11.136

5.  Exercise and substance use among American youth, 1991-2009.

Authors:  Yvonne M Terry-McElrath; Patrick M O'Malley; Lloyd D Johnston
Journal:  Am J Prev Med       Date:  2011-05       Impact factor: 5.043

6.  Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.

Authors:  Tiina Saanijoki; Lauri Tuominen; Jetro J Tuulari; Lauri Nummenmaa; Eveliina Arponen; Kari Kalliokoski; Jussi Hirvonen
Journal:  Neuropsychopharmacology       Date:  2017-07-19       Impact factor: 7.853

7.  The effects of morphine, naloxone, and κ opioid manipulation on endocrine functioning and social behavior in monogamous titi monkeys (Callicebus cupreus).

Authors:  B J Ragen; N Maninger; S P Mendoza; K L Bales
Journal:  Neuroscience       Date:  2014-12-06       Impact factor: 3.590

Review 8.  Pain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanisms.

Authors:  Stephen Bruehl; John W Burns; Ok Y Chung; Melissa Chont
Journal:  Neurosci Biobehav Rev       Date:  2008-12-25       Impact factor: 8.989

9.  Exercise-based smoking cessation interventions among women.

Authors:  Sarah E Linke; Joseph T Ciccolo; Michael Ussher; Bess H Marcus
Journal:  Womens Health (Lond)       Date:  2013-01

10.  The effect of environmental factors on morphine withdrawal in C57BL/6J mice: running wheel access and group housing.

Authors:  Rebecca E Balter; Linda A Dykstra
Journal:  Psychopharmacology (Berl)       Date:  2012-08-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.